System and method of guided treatment within malignant prostate tissue
US8548562B2 · kind B2 · utility
Inventors
Key dates
| Filing date | Mar 16, 2007 |
| Grant date | Oct 1, 2013 |
| Priority date | — |
| Expiry date | Mar 9, 2031 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61N7/02
- WIPO fieldMedical technology
- WIPO sectorInstruments
Abstract
An imaging and diagnostic system and method to differentiate between malignant and non-malignant tissue of a prostate and surrounding region. The system acquires imaging data from the prostate and surrounding proximal region, and processes the data to differentiate areas of tissue malignancy from non-malignant tissue. A sectioning device or ablative device is provided. The ablative device is operable by automation for receiving the imaging output coordinates and defining the trajectory and quantity of energy or power to be delivered into the malignant tissue. A control system determines calculated energy or power to be deposited into the malignant tissue during ablation, to minimize destruction of the non-malignant tissue within the prostate and surrounding tissue. The system operates on generated ablative device output data.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.